Skip to main content
. 2021 Sep 19;10(2):1567–1578. doi: 10.1007/s40122-021-00312-6

Table 2.

Changes in the number (%) of patients with symptoms during the study

Symptom Total (N = 83) MPFF group (n = 42) Control group (n = 41)
Day 0 Day 0 Day 61 Day 0 Day 61
Lower abdominal pain 73 (88%) 36 (85.7%) 31 (73.8%) 37 (90.2%) 37 (90.2%)
Lower abdominal heaviness 69 (83.1%) 34 (80.1%) 29 (69%) 35 (85.4%) 38 (92.7%)
Pain in the sacrum and coccyx 68 (82%) 34 (80.1%) 32 (76.2%) 34 (82.9%) 33 (80.5%)
Lower abdominal discomfort 67 (80.7%) 32 (76.2%) 27 (64.3%) 35 (85.4%) 37 (90.2%)
Dyspareunia 63 (75.9%) 29 (69%) 26 (61.9%) 34 (82.9%) 34 (82.9%)
Dysuria 51 (61.4%) 33 (78.6%) 27 (64.3%) 18 (43.9%) 20 (48.8%)
Tenderness in the perineum 49 (59%) 25 (59.5%) 18 (42.9%) 24 (58.5%) 26 (63.4%)
Edema in the perineum 46 (55.4%) 25 (59.5%) 20 (47.6%) 21 (51.2%) 22 (53.7%)
Menstrual disorders 45 (54.2%) 21 (50%) 20 (47.6%) 24 (58.5%) 27 (65.9%)
Signs of atypical varicosis 38 (45.8%) 20 (47.6%) 20 (47.6%) 18 (43.9%) 20 (48.8%)
Mean number of symptoms per patient (mean ± SD)
6.9 ± 2.6 6.9 ± 3.0 6.0 ± 3.2 6.8 ± 2.2 7.2 ± 2.0